- Home
- Clinical Trials
Cardiovascular Study Palmerston North 79
Cardiovascular Study
Palmerston North
Are you at high risk of or have you recently had a heart attack, stroke, or surgery for blocked arteries?
You may be eligible to participate in a clinical research study investigating a potential new medication aimed at reducing the risk of serious future heart and circulation events.
This study could lead to a potential new treatment option that not only better controls cholesterol levels but may also help prevent life-threatening cardiovascular problems and improve long-term health outcomes.
Description
What to expect
Study details
Ages
18 years or older
Duration
Up to 4.5 years and includes approximately 13–15 scheduled clinic visits over the course of the study along with additional safety check-ins.
Compensation
Participants will be compensated up to $1,875
Eligibility Criteria
You may qualify for this study if you:
- Are aged 18 years or older
- Are taking cholesterol lowering medication
- Have had a heart attack, stroke, or artery surgery within the past 12 months.
OR
- Are male 50 years or older or female 55 years and older.
- Are taking cholesterol lowering medication.
- Are at a high risk of a heart event due to blocked arteries or diabetes with organ damage.
Other eligibility criteria will apply.
Locations
Description
Atherosclerotic cardiovascular disease (ASCVD) is a chronic, life-threatening condition caused by the build-up of plaque in the arteries, leading to reduced blood flow. This can result in heart attacks, strokes, and poor circulation—often with lasting consequences.
Even with today’s treatments, such as statins and other cholesterol-lowering medications, many people still have high levels of LD (“bad”) cholesterol, putting them at continued risk of serious cardiovascular events.
Living with ASCVD can mean ongoing medical care, limited physical activity, and an increased risk of unexpected health emergencies. For those who have already experienced a heart attack, stroke, or related surgery—or who are considered high risk—proactive management is essential.
This study is evaluating an investigational medication that may further lower LDL Cholesterol and help reduce the risk of future cardiovascular events when taken alongside your current cholesterol-lowering therapy.
Researchers hope this medication will offer an additional layer of protection beyond what current treatments provide.
By taking part, you’ll be helping to advance scientific understanding and contribute to research that could improve outcomes for millions of people with or at risk for cardiovascular disease.
What to expect
If you qualify and choose to participate, you’ll be randomly assigned to receive either the investigational medication or a placebo (an inactive tablet)—taken once daily alongside your current cholesterol-lowering medications.
Throughout the study, you’ll attend scheduled clinic visits where our experienced team will monitor your heart health and general wellbeing.
These visits will include:
- Blood tests
- Vital sign measurements
- Heart health assessments (e.g., ECGs)
- Questionnaires about your lifestyle and health
Our clinical team will closely track your safety and progress every step of the way.
Why Participate?
- Access expert care and regular heart health monitoring
- Contribute to research that may lead to new treatment options
- Help advance care for people with ASCVD worldwide
- All study-related care and medications provided at no cost
- Eligible participants will receive compensation for time and travel
Register your interest now and find out if participating in this study is right for you.
Your privacy is important to us—any information you share will be kept strictly confidential.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research NZ is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. Our Privacy Policy also contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.